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Management of Ovarian 
Masses During Pregnancy 
Vincent Y.T. Cheung, MBBS, FRCOG, FRCSC
INTRODUCTION
Ultrasonography has been widely used 
as a routine component of antenatal 
care. During the assessment of the fetus 
and the placenta, an adnexal mass may 
be discovered at the time of the ultra-
sound examination. Occasionally, an ad-
nexal mass can also be suspected either 
on physical examination or as a result of 
clinical symptoms.
The identiocation of an adnexal le-
sion during pregnancy may pose a di-
agnostic and management challenge to 
the physician. Although most of these 
adnexal masses are functional ovarian 
cysts and generally will resolve during 
pregnancy, 0.7% to 1.7% of these mass-
es will persist through the rest of the 
pregnancy.1,2 Ovarian cyst complications 
such as torsion, haemorrhage, or rupture 
are uncommon during pregnancy. How-
ever, some women may require emer-
gency surgery for these complications. 
Familiarity with the natural history 
and sonographic features of common 
adnexal lesions such as simple cysts, 
mature cystic teratomas, endometriotic 
cysts, and ovarian conditions specioc to 
pregnancy, such as ovarian hyperstim-
ulation, hyperreactio luteinalis and lute-
omas, are important when evaluating a 
pregnant woman with an adnexal mass.
PREVALENCE OF ADNEXAL 
MASSES DETECTED DURING 
PREGNANCY
In a study with more than 10,000 preg-
nant patients, it was shown that the 
prevalence of a simple cyst measuring 
3 cm or greater was 5.3% at 8 to 10 
weeks of gestational age; spontaneous 
regression began after 10 weeks, drop-
ping to 1.5% prevalence by 14 weeks.3 
In a cross-sectional study of 2,245 wom-
en scanned at the end of the orst trimes-
ter, 1.2% of the total number of cysts 
detected persisted beyond 16 weeks.4 
Also, according to two large prospec-
tive studies which followed close to 
3,000 women with adnexal cysts till 6 to 
8 weeks postpartum, the incidence of 
adnexal masses during pregnancy be-
fore 14 weeks of gestation varied from 
6% to 25%.1,2 Most of these adnexal 
masses were functional ovarian cysts 
Key points
•  Adnexal masses are commonly detected during pregnancy, and the ma-
jority of these masses will resolve. 
•  Most ovarian masses identiﬁed during pregnancy are benign. Rate of ma-
lignancy (including borderline tumours) for persistent masses is approxi-
mately 3%-4%.
•  Ultrasound is often the best and the ﬁrst-line imaging modality in the eval-
uating of adnexal masses in pregnancy.
•  Ovarian torsion, although uncommon, may complicate patients who are 
managed expectantly.
•  Observation is a reasonable approach in a pregnant woman with an 
asymptomatic adnexal mass with ultrasound features not concerning for 
malignancy.
•  Laparoscopy in the second trimester can be safely performed, with some 
modiﬁcation in techniques. 
•  Patients with ovarian cyst identiﬁed during pregnancy should be informed 
of the risks and beneﬁts of intervention, and the ultimate management 
plan should be an informed decision by the patient based on the informa-
tion provided by the physician.  
The identiocation of an adnexal lesion during 
pregnancy may pose a diagnostic and 
management challenge
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and resolved during pregnancy, leaving 
between 0.8% and 1.7% of women with 
persistent masses.1,2 Ovarian cysts that 
have resolved spontaneously are pre-
sumed to be physiological cysts that a 
conservative management strategy can 
be considered. It is clear that the persis-
tent masses require further diagnostic 
and management decisions. 
HISTOLOGICAL DIAGNOSES
Ovarian lesions unique to pregnancy 
Ovarian conditions unique to pregnancy 
include hyperstimulated ovaries and less 
commonly, hyperreactio luteinalis, theca 
lutein cysts, and luteomas. These condi-
tions, with the exception of luteomas of 
pregnancy, are typically bilateral, aiding 
in their recognition. 
Hyperstimulated ovaries represent 
a response to elevated circulating lev-
els of human chorionic gonadotropin 
(hCG), typically occur in patients who 
have undergone ovulation induction, 
thus presenting in the orst trimester. It 
can be associated with various degree 
of severity of ovarian hyperstimulation 
syndrome. Hyperreactio luteinalis is 
an abnormal hypersensitive response 
to circulating levels of hCG, in the ab-
sence of any ovulation induction ther-
apy. Up to 60% occur in a singleton 
pregnancy with normal circulating level 
of hCG. Theca lutein cysts are sono-
graphically similar to the above condi-
tions with bilateral enlarged ovaries with 
multiple cysts. They represent a normal 
response of the ovaries to elevated lev-
els of hCG associated with gestational 
trophoblastic disease. 
Luteoma is a rare benign process 
unique to pregnancy, in which the ovar-
ian parenchyma is replaced by the pro-
liferation of luteinized stromal cells that 
may be associated with the production 
of androgens. Virilization can occur in 
25% to 30% of the women and in 50% 
of the female fetus.5 Conservative ther-
apy is appropriate because the ovaries 
and serum testosterone levels usually 
return to normal by several weeks post-
partum. 
Ectopic ovarian pregnancy, al-
though rare, can occur as an isolated 
condition or, in the context of this arti-
cle, as part of heterotopic pregnancy 
and should also be considered when an 
ovarian mass is identioed during preg-
nancy. 
Benign ovarian lesions
As in non-pregnant women, most ovar-
ian masses identioed during pregnancy 
are benign, and among those, the most 
common ones reported are mature cyst-
ic teratoma (36.4% - 42.8%), endometri-
oma (7.3% - 24.2%), and serous and mu-
cinous cystadenoma (13.0% - 15.2%).2,6,7
The corpus luteum of pregnancy, 
despite being typically described sono-
graphically as a low-resistance Doppler 
pattern, and often called the “ring of 
ore­,8 also has a varied appearance and 
can be inadvertently resected surgically 
during pregnancy. Occasionally it can 
be partially resected or biopsied during 
surgery for histological diagnosis and 
has been reported to be responsible for 
8.6% - 13% of ovarian masses identioed 
during pregnancy.6,7
Malignant ovarian lesions
One of the main concerns with the identi-
ocation of an adnexal mass during preg-
nancy is the risk of malignancy and the 
potential in the delay in the diagnosis 
and treatment of ovarian cancer. In most 
of the published series, the reported in-
cidence of ovarian cancer in pregnancy 
ranges from 1 in 5,000 to 1 in 47,000 live 
births, with 2% to 6% of persistent adnex-
al masses found to be malignant.9 From 
our own series of 35 pregnant women, 
the rate of malignancy was 1 in 10,000 
live births, or 8.6% of persistent masses, 
which is comparable with the reported 
rates.6 However, these reported rates de-
pend on the selection criteria by which 
an adnexal mass would be removed dur-
ing pregnancy. In a retrospective study 
of 60 adnexal masses resected during 
Figure B. Laparoscopic view showing a 
15-week pregnant uterus (U) and a right 
ovarian cyst (C).
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Figure A. Sonogram showing a multiloculated 
ovarian cyst (C) identiﬁed at the left side of 
the pregnant uterus. F = fetus, P = placenta.
As in non-pregnant women, most ovarian masses 
identioed during pregnancy are benign
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pregnancies over a 12-year period, a ma-
lignancy rate of up to 13% had been re-
ported,9 whereas the rate of malignancy 
(including borderline tumours) obtained 
from longitudinal studies that followed 
the adnexal masses from early pregnan-
cy till the postpartum period, was found 
to be lower (3.6% - 4.3%).1,10,11
ULTRASOUND EVALUATION 
OF OVARIAN MASSES DURING 
PREGNANCY
Although the overall risk of ovarian malig-
nancy among pregnant women with pel-
vic masses is low, the anxiety generated 
for both the patient and the health care 
team is substantial. Careful ultrasound 
evaluation of these masses is important 
to guide subsequent management. In 
addition, this information will become 
valuable if an acute clinical situation de-
velops later in pregnancy. It is generally 
accepted that the ultrasound character-
istics of different types of adnexal mass-
es do not differ between pregnant and 
non-pregnant women.12 It is beyond the 
scope of this article to review in detail 
the ultrasound appearances of different 
ovarian masses. Interested readers are 
advised to refer to related review arti-
cles, and the consensus opinion from 
the International Ovarian Tumor Analysis 
(IOTA) group.13,14
Tumour size, as well as architectur-
al features including nodularities, excres-
cences, papillary projections, and septa-
tions appear to be important indicators 
of malignancy. Most studies have found 
that the majority of malignant masses in 
pregnant women are > 5 cm in diame-
ter and are complex in appearance.10,11,15 
Schmeler et al. in their review reported 
that all malignant and borderline tu-
mours were complex in appearance by 
ultrasound, compared to only 30% of 
the benign masses.15 However, despite 
a number of algorithms and mathemati-
cal models that have been developed in 
the evaluation of ovarian masses, many 
investigators have concluded that expert 
opinion on ultrasound remains more ac-
curate than specioc sonographic char-
acteristics in differentiating benign and 
malignant tumours.16,17 
THE ROLE OF MRI
Although not routinely used in the as-
sessment of ovarian masses, magnet-
ic resonance imaging (MRI) may bring 
additional information to ultrasound and 
can be used as an adjunct in character-
izing ovarian lesions found during preg-
nancy. However, when considering an 
MRI for a pregnant woman, physicians 
should evaluate the risk-beneot ratio be-
fore determining the necessity of this im-
aging modality. 
RISK OF COMPLICATIONS
Another concern with the onding of an 
adnexal mass during pregnancy is the 
possibility of complications, notably 
ovarian torsion. The reported rate of tor-
sion is highly variable. While Condous 
et al. in their prospective study report-
ed suspected and likely torsion rates of 
2.5% and 0.6%, respectively,1 and Yaz-
bek et al. reported a 0% torsion rate,2 
some investigators have suggested a 
rate of up to 14.8%.18 In a more recent 
observational study involving 803 wom-
en with ovarian masses identioed before 
24 weeks of pregnancy and with fol-
low-up throughout the pregnancy and 
delivery, 5 women required emergency 
surgery: 3 (0.4%) for torsion and 2 (0.2%) 
for rupture of the mass.10 The risk of tor-
sion appeared to increase with the size 
of the mass and was greatest prior to 20 
weeks of gestation.18 
MANAGEMENT ISSUES
The onding of an adnexal mass during 
pregnancy is particularly challenging, as 
the risks to the mother must be weighed 
against the potential fetal complications 
of surgery. In a review of over 2 million 
deliveries from the Swedish Health Reg-
istry, infants born after laparoscopy or 
laparotomy performed during pregnan-
cy were more often preterm, low birth 
weight, and growth restricted.19 These 
ondings were also supported by another 
study which noted that 12% of deliver-
ies after adnexal surgery were preterm, 
while 3% of the pregnancies ended with 
a spontaneous miscarriage and 5% with 
a perinatal death.20
The incidence of fetal loss after sur-
gery for adnexal masses during preg-
nancy is difocult to assess as most stud-
ies are not prospective in nature with no 
comparative group. The time from oper-
ation to fetal loss is not deoned. oo et 
al. in 2012 reported a fetal loss rate of 
1.9% within 3 weeks of surgery,7 where-
as Yuen et al. reported a fetal loss out of 
67 cases (1.6%) which occurred 6 weeks 
after surgery.21 In our own series, there 
was one fetal loss (2.9%) on the second 
day after surgery.6
Surgical removal of an adnexal 
mass is generally avoided during the 
orst trimester of pregnancy as during 
this period spontaneous miscarriage 
is relatively more common and subse-
quent spontaneous resolution of the 
mass may occur. Although ovarian cyst 
torsion, haemorrhage, or rupture is un-
common, some women may require 
emergency surgery during pregnancy 
for these complications. Pregnant wom-
en with persistent masses may also 
prefer to have surgery in the second 
trimester if malignancy is suspected 
on sonography or to avoid cyst compli-
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cations, which may necessitate emer-
gency surgery, and potentially adds an 
increased risk for complications.22 This 
was suggested in a study by Whitecar 
et al. which showed that women who 
underwent laparotomy after 23 weeks’ 
gestation had a >50% risk of adverse 
perinatal outcome.22
SAFETY OF LAPAROSCOPY 
DURING PREGNANCY
Surgery during the second trimester of 
pregnancy poses a technical challenge, 
especially if laparoscopic surgery is per-
formed. One potential complication is 
the inadvertent injury of the gravid uterus 
by the Veress needle or trocar, causing 
bleeding, leakage of amniotic quid, or 
miscarriage. Furthermore, there may 
be difoculty achieving adequate visuali-
zation because of the limited space be-
tween the laparoscope and the adnexal 
mass, especially if the umbilical trocar is 
used for laparoscope insertion.
Laparoscopic treatment of adnexal 
masses in pregnancy has been consid-
ered safe and effective.6 Studies have 
demonstrated that laparoscopic surgery 
during pregnancy offers good maternal 
outcomes, such as shortened length of 
hospital stay, early return of bowel func-
tion, early ambulation, low rate of wound 
infection and less pain after surgery.23 
On the other hand, despite the lack of 
evidence, it is suggested that fetal out-
comes seem to be less favourable in lap-
aroscopy than laparotomy, because of 
the need for carbon dioxide (CO2) pneu-
moperitoneum and increased abdomi-
nal pressure during laparoscopy.24 The 
Guidelines for diagnosis, treatment, and 
use of laparoscopy for surgical problems 
during pregnancy, published by the So-
ciety of American Gastrointestinal and 
Endoscopic Surgeons (SAGES) in 2011, 
reassured the safety of laparoscopy dur-
ing pregnancy, including the use of CO2 
insufqation of 10-15 mmHg.25 
There has been much debate re-
garding abdominal access in a pregnant 
patient with preferences toward either a 
Hasson technique or Veress needle in-
sertion. The concern for use of the Ver-
ess needle has largely been based on 
the risk of injury to the uterus or other 
intraabdominal organs. 
SAGES Guidelines suggest that 
both the Hassan technique and Veress 
needle can be safely and effectively 
used if the site of initial abdominal ac-
cess is adjusted according to the fundal 
height and the abdominal wall is ade-
quately elevated during insertion.25 The 
left upper quadrant approach, used ex-
tensively in patients at high risk of peri-
umbilical adhesions, has been used in 
our unit and has been shown to be safe 
and feasible to be used in the second 
trimester of pregnancy.6,26 In our expe-
rience, another advantage of the left 
upper quadrant approach compared 
with the traditional umbilical placement 
of the trocar is that it provides better 
panoramic vision by allowing adequate 
distance between the laparoscope and 
the adnexal mass. Moreover, with the 
primary laparoscopic access at the left 
upper quadrant, most of the intended 
surgeries can be completed without 
the need for an additional trocar place-
ment at the umbilicus. Although ultra-
sound guided trocar placement has 
been described in the literature as an 
additional safeguard to avoid uterine 
injury, this has not been widely prac-
tised.27 
Evidence has accumulated to 
suggest that the clinical outcomes of 
laparoscopy are equivalent to those of 
laparotomy, while conferring all of the ad-
vantages of the laparoscopic approach.7 
Reedy et al. found that there was no 
difference in intrauterine growth restric-
tion or stillbirth between laparoscopy 
and laparotomy in their 20-year study.19 
Oelsner et al. reported a lower rate of 
postoperative complications, such as 
maternal fever and pulmonary embolus, 
although there were similar rates for fe-
tal outcomes, such as abortion, preterm 
labour and intrauterine growth restriction 
between laparoscopy and laparotomy.28 
It was also suggested that laparoscopic 
surgery was associated with reduced 
narcotic use, contributing to less fetal 
depression and reduced manipulation of 
the uterus, which resulted in less uterine 
irritability and, consequently, less pre-
term labour.23
SELECTION OF CASES
Given the potential complications of 
surgery during pregnancy, the decision 
whether to operate on an adnexal mass 
or to observe is often difocult. Despite 
the increased frequency with which ad-
nexal masses are now diagnosed during 
pregnancy, there is still a lack of consen-
sus recommendations to guide clinicians 
on its management. 
Several investigators have sug-
gested that observation is a reasonable 
approach in the majority of women,8,10 
especially when ultrasound ondings are 
not concerning for malignancy. 
The American College of Obstetri-
cians and Gynecologists has also sug-
gested that adnexal masses in preg-
nancy appear to have low risk for both 
malignancy and acute complications, 
they may be considered for expectant 
management.29 If the nature of an adnex-
al mass is indeterminate or suspicious of 
malignancy, a multidisciplinary approach 
is recommended. This includes the radi-
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ologist, the obstetrician, the gynaeco-
logical oncologist and the gynaecologist 
specialized in minimally invasive surgery 
to ensure proper selection of patients 
that may require operative intervention 
and optimize the timing of surgery. 
Obviously, in the acutely sympto-
matic pregnant patient, surgery may be 
performed in any trimester. Laparoscopy 
can be considered for both diagnosis 
and treatment of adnexal torsion unless 
clinical severity warrants laparotomy, as 
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dictated by the patient’s clinical condi-
tion and operative ondings.25 
CONCLUSIONS
Diagnostic and management algorithms 
for patients with adnexal masses compli-
cating pregnancy depend on the clinical 
symptoms, the timing of detection, the 
natural history and sonographic features 
of the adnexal masses. Ultrasound is a 
valuable diagnostic tool, which can strat-
ify adnexal masses into low or high risk of 
malignancy and thus aids signiocantly in 
deciding on expectant versus operative 
treatment strategy. Patients with ovarian 
cyst identioed during pregnancy should 
be informed of the risks and beneots of 
intervention, in order to enable them to 
make an ultimate informed management 
decision.
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